As per the roadmap, India can scale its Bio Economy to $691 billion by 2035and $2.6 trillion by 2047 creating over 30 million high-value jobs.
Status of India’s Bioeconomy
- Status: Expanded sixteen-fold from $10 billion (2014) to $195.3 billion (2025) contributing 4.8% to national GDP.
- It already employs over 3.3 million professionals and supports ~12,000 startups.
Key Recommendations
- Shifting from fragmented to Flagship Missions: E.g. GeneIndia (gene and cell therapy); AgriBio 2.0 (quality assured bioinputs); BioX Foundry (industrial biotech innovations); One Health Grid (AI-assisted disease detection), etc.
- Cross-Ministerial Governance Structure: E.g. through an Empowered Committee on National BioMissions; National BioData Council; BioEconomy Investment & Policy Forum; Dedicated Bio-IP Accelerated Pathway.
- Financing: Creation of a ₹50,000-crore BioEconomy Growth Fund (2026–2035) to deploy blended finance, catalytic equity and infrastructure support.
- Regulation: Differentiated approval pathways for frontier modalities like cell and gene therapies, synthetic biology, modernization of CDSCO (Central Drugs Standard Control Organisation), etc.
- Strengthening Talent Pipeline: Experiential and Immersion-based learning, Re-entry pathways for diaspora scientists, and a vibrant entrepreneurship ecosystem.
Global Best Practices
|
